Income Statement Altimmune, Inc.

Equities

ALT

US02155H2004

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 12:39:10 2024-09-10 EDT			5-day change	1st Jan Change
6.730 ^USD	+5.49%		+3.76%	-41.16%

08-15	Altimmune, Inc. Announces That David J. Drutz Will Not Stand for Re-Election to the Board	CI
08-08	Transcript : Altimmune, Inc., Q2 2024 Earnings Call, Aug 08, 2024

e.AEGGFuS4Y0mvTAP7W-Axi6c_cGxqtnhp2KlmIGCvmds.eArrcpPvDD7MKTLOFalexZZMEVgi0zQdkvkFf1ma7ZRwDbFvos1VBso4Vg

Published financial data: ALTIMMUNE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	5.8M	8.19M	4.41M	-68K	426K
Total Revenues	5.8M	8.19M	4.41M	-68K	426K
Cost of Goods Sold, Total	17.09M	33.51M	73.84M	70.45M	65.8M
Gross Profit	-11.28M	-25.32M	-69.43M	-70.52M	-65.37M
Selling General & Admin Expenses, Total	8.5M	13.21M	15.41M	17.13M	18.14M
Other Operating Expenses, Total	8.5M	13.21M	15.41M	17.13M	18.14M
Operating Income	-19.78M	-38.53M	-84.84M	-87.65M	-83.51M
Interest Expense, Total	-2.24K	-9.42K	-5.66K	-8K	-35K
Interest And Investment Income	843K	323K	203K	2.87M	7.35M
Net Interest Expenses	841K	313K	197K	2.86M	7.32M
Other Non Operating Income (Expenses)	45.14K	24.15K	-374K	-32K	166K
EBT, Excl. Unusual Items	-18.9M	-38.2M	-85.02M	-84.82M	-76.03M
Merger & Related Restructuring Charges	-680K	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Asset Writedown	-1M	-	-11.37M	-	-12.42M
In Process R&D Expenses	-	-	-	-	-
Other Unusual Items	-	-16.27M	-700K	-86K	-
EBT, Incl. Unusual Items	-20.58M	-54.46M	-97.09M	-84.91M	-88.45M
Income Tax Expense	-58.5K	-5.42M	-	-197K	-
Earnings From Continuing Operations	-20.52M	-49.04M	-97.09M	-84.71M	-88.45M
Net Income to Company	-20.52M	-49.04M	-97.09M	-84.71M	-88.45M
Net Income - (IS)	-20.52M	-49.04M	-97.09M	-84.71M	-88.45M
Preferred Dividend and Other Adjustments	453K	-	-	-	-
Net Income to Common Incl Extra Items	-20.97M	-49.04M	-97.09M	-84.71M	-88.45M
Net Income to Common Excl. Extra Items	-20.97M	-49.04M	-97.09M	-84.71M	-88.45M
Per Share Items
Net EPS - Basic	-1.6	-1.91	-2.35	-1.81	-1.66
Basic EPS - Continuing Operations	-1.6	-1.91	-2.35	-1.81	-1.66
Basic Weighted Average Shares Outstanding	13.12M	25.64M	41.28M	46.93M	53.25M
Net EPS - Diluted	-1.6	-1.91	-2.35	-1.81	-1.66
Diluted EPS - Continuing Operations	-1.6	-1.91	-2.35	-1.81	-1.66
Diluted Weighted Average Shares Outstanding	13.12M	25.64M	41.28M	46.93M	53.25M
Normalized Basic EPS	-0.9	-0.93	-1.29	-1.13	-0.89
Normalized Diluted EPS	-0.9	-0.93	-1.29	-1.13	-0.89
Supplemental Items
EBITDA	-19.4M	-38.24M	-84.29M	-87.61M	-83.03M
EBITA	-19.64M	-38.49M	-84.82M	-87.65M	-83.51M
EBIT	-19.78M	-38.53M	-84.84M	-87.65M	-83.51M
EBITDAR	-19.05M	-37.83M	-83.79M	-87.11M	-82.53M
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	0.28	9.95	-	0.23	-
Current Domestic Taxes	-	-5.42M	-	-197K	-
Total Current Taxes	-	-5.42M	-	-197K	-
Deferred Domestic Taxes	-58.5K	-	-	-	-
Total Deferred Taxes	-58.5K	-	-	-	-
Normalized Net Income	-11.81M	-23.87M	-53.14M	-53.02M	-47.52M
Interest on Long-Term Debt	2.24K	9.42K	-	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	8.5M	13.21M	15.41M	17.13M	18.14M
Research And Development Expense From Footnotes	18.77M	49.77M	74.54M	70.54M	65.8M
Net Rental Expense, Total	347K	407K	500K	500K	500K
Imputed Operating Lease Interest Expense	5.37K	17.2K	13.46K	24.07K	156K
Imputed Operating Lease Depreciation	341K	390K	487K	476K	344K
Stock-Based Comp., COGS (Total)	357K	358K	1.66M	2.84M	4.76M
Stock-Based Comp., G&A Exp. (Total)	908K	2.22M	3.86M	5.27M	5.88M
Total Stock-Based Compensation	1.26M	2.58M	5.52M	8.1M	10.64M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	8.96M	116M	190M	111M	135M
Short Term Investments	28.28M	100M	-	73.78M	62.7M
Total Cash And Short Term Investments	37.24M	216M	190M	185M	198M
Accounts Receivable, Total	1.02M	4.61M	429K	173K	1.11M
Other Receivables	629K	7.76M	5.41M	2.37M	3.74M
Total Receivables	1.65M	12.37M	5.84M	2.54M	4.85M
Prepaid Expenses	470K	1.93M	7.95M	5.36M	6.82M
Restricted Cash	34.17K	34.17K	34.17K	34K	41K
Other Current Assets, Total	-	-	-	-	100K
Total Current Assets	39.39M	230M	204M	193M	210M
Gross Property Plant And Equipment	3.15M	3.56M	4.29M	3.18M	2.99M
Accumulated Depreciation	-1.35M	-1.6M	-2.05M	-1.5M	-1.98M
Net Property Plant And Equipment	1.8M	1.96M	2.25M	1.68M	1.01M
Goodwill	-	-	-	-	-
Other Intangibles, Total	12.73M	12.82M	12.42M	12.42M	-
Other Long-Term Assets, Total	129K	73.41K	73.8K	19K	-
Total Assets	54.06M	245M	219M	207M	211M
Liabilities
Accounts Payable, Total	18.23K	612K	2.03M	4.8M	2.07M
Accrued Expenses, Total	3.58M	11.03M	9.74M	10.63M	9.58M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	259K	357K	411K	452K	496K
Current Income Taxes Payable	-	-	-	1.17M	-
Unearned Revenue Current, Total	61.56K	19.75K	-	-	-
Other Current Liabilities	-	-	6.09M	-	-
Total Current Liabilities	3.92M	12.02M	18.28M	17.05M	12.14M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	1.48M	1.47M	1.12M	672K	175K
Unearned Revenue Non Current	250K	250K	250K	250K	160K
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	2.88M	5.5M	80.54K	3.66M	4.06M
Total Liabilities	8.54M	19.24M	19.73M	21.64M	16.54M
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	1.51K	3.7K	4.09K	5K	7K
Additional Paid In Capital	188M	417M	497M	568M	665M
Retained Earnings	-137M	-186M	-293M	-378M	-466M
Comprehensive Income and Other	-5.02M	-5.04M	-5.04M	-5.23M	-5M
Total Common Equity	45.52M	226M	199M	185M	194M
Total Equity	45.52M	226M	199M	185M	194M
Total Liabilities And Equity	54.06M	245M	219M	207M	211M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	15.13M	36.98M	42.92M	49.28M	70.9M
ECS Total Common Shares Outstanding	15.08M	36.97M	40.69M	49.2M	70.68M
Book Value / Share	3.02	6.11	4.89	3.77	2.75
Tangible Book Value	32.79M	213M	187M	173M	194M
Tangible Book Value Per Share	2.17	5.76	4.59	3.51	2.75
Total Debt	1.74M	1.82M	1.54M	1.12M	671K
Net Debt	-35.5M	-214M	-189M	-184M	-197M
Debt Equivalent Oper. Leases	2.77M	3.26M	4M	4M	4M
Account Code - Inventory Valuation	3	3	3	-	3
Machinery, Total	1.2M	1.31M	1.55M	652K	699K
Full Time Employees	25	43	47	52	59

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-20.52M	-49.04M	-97.09M	-84.71M	-88.45M
Depreciation & Amortization - CF	240K	251K	531K	-205K	477K
Amortization of Goodwill and Intangible Assets - (CF)	148K	46.81K	19.92K	-	-
Depreciation & Amortization, Total	387K	298K	551K	-205K	477K
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-2.47M
Asset Writedown & Restructuring Costs	7.54M	-	11.95M	-	12.42M
Stock-Based Compensation (CF)	1.26M	2.58M	5.52M	8.1M	10.64M
Other Operating Activities, Total	-35.76K	16.25M	1.08M	120K	-154K
Change In Accounts Receivable	2.44M	-3.59M	4.18M	256K	-938K
Change In Accounts Payable	-355K	594K	1.42M	2.77M	-2.73M
Change in Unearned Revenues	22.03K	-	-	-	-
Change In Income Taxes	380K	-7.13M	2.35M	3.04M	-1.37M
Change In Deferred Taxes	-58.5K	-	-	-	-
Change in Other Net Operating Assets	-669K	5.62M	-8.21M	8.04M	-3.23M
Cash from Operations	-9.6M	-34.44M	-78.24M	-62.59M	-75.81M
Capital Expenditure	-1.23K	-204K	-12.12M	-126K	-47K
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-27.77K	-138K	-195K	-	-
Investment in Marketable and Equity Securities, Total	-28.26M	-71.75M	99.83M	-73.27M	13.78M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-28.29M	-72.09M	87.52M	-73.4M	13.73M
Short Term Debt Issued, Total	-	632K	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	632K	-	-	-
Short Term Debt Repaid, Total	-	-632K	-	-	-
Long-Term Debt Repaid, Total	-292K	-	-	-	-
Total Debt Repaid	-292K	-632K	-	-	-
Issuance of Common Stock	12.7M	213M	65.22M	56.78M	86.93M
Repurchase of Common Stock	-	-	-	-	-539K
Issuance of Preferred Stock	-	-	-	-	-
Repurchase of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	125K	-	-119K	-	-285K
Cash from Financing	12.53M	213M	65.1M	56.78M	86.1M
Foreign Exchange Rate Adjustments	-	-	-	-	-
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-25.36M	107M	74.38M	-79.2M	24.03M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Levered Free Cash Flow	-8.04M	-25.74M	-52.56M	-42.39M	-49.98M
Unlevered Free Cash Flow	-8.04M	-25.73M	-52.56M	-42.38M	-49.96M
Change In Net Working Capital	-2.71M	4.18M	-6.71M	-4.63M	8.83M
Net Debt Issued / Repaid	-292K	0	-	-	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-22.73	-16.1	-22.86	-25.73	-25
Return on Total Capital	-25.72	-17.52	-24.76	-28.31	-27.38
Return On Equity %	-43.74	-36.14	-45.69	-44.07	-46.63
Return on Common Equity	-44.7	-36.14	-45.69	-44.07	-46.63
Margin Analysis
Gross Profit Margin %	-194.51	-309.4	-1.57K	104K	-15.35K
SG&A Margin	146.53	161.39	349.48	-25.2K	4.26K
EBITDA Margin %	-334.36	-467.14	-1.91K	129K	-19.49K
EBITA Margin %	-338.49	-470.21	-1.92K	129K	-19.6K
EBIT Margin %	-341.04	-470.78	-1.92K	129K	-19.6K
Income From Continuing Operations Margin %	-353.71	-599.2	-2.2K	125K	-20.76K
Net Income Margin %	-353.71	-599.2	-2.2K	125K	-20.76K
Net Avail. For Common Margin %	-361.52	-599.2	-2.2K	125K	-20.76K
Normalized Net Income Margin	-203.6	-291.66	-1.2K	77.96K	-11.15K
Levered Free Cash Flow Margin	-138.55	-314.44	-1.19K	62.34K	-11.73K
Unlevered Free Cash Flow Margin	-138.53	-314.37	-1.19K	62.33K	-11.73K
Asset Turnover
Asset Turnover	0.11	0.05	0.02	-0	0
Fixed Assets Turnover	3.69	4.35	2.1	-0.03	0.32
Receivables Turnover (Average Receivables)	2.59	2.91	1.75	-0.23	0.66
Short Term Liquidity
Current Ratio	10.04	19.16	11.17	11.31	17.26
Quick Ratio	9.91	18.99	10.73	10.99	16.69
Operating Cash Flow to Current Liabilities	-2.45	-2.86	-4.28	-3.67	-6.24
Days Sales Outstanding (Average Receivables)	141.03	125.91	208.51	-1.62K	550.07
Average Days Payable Outstanding	4.18	3.44	6.54	17.71	19.07
Long Term Solvency
Total Debt/Equity	3.83	0.81	0.77	0.61	0.35
Total Debt / Total Capital	3.69	0.8	0.76	0.6	0.34
LT Debt/Equity	3.26	0.65	0.56	0.36	0.09
Long-Term Debt / Total Capital	3.14	0.64	0.56	0.36	0.09
Total Liabilities / Total Assets	15.79	7.85	9.01	10.46	7.85
EBIT / Interest Expense	-8.82K	-4.09K	-15K	-10.96K	-2.39K
EBITDA / Interest Expense	-8.49K	-4.02K	-14.81K	-10.89K	-2.36K
(EBITDA - Capex) / Interest Expense	-8.49K	-4.04K	-16.96K	-10.9K	-2.36K
Total Debt / EBITDA	-0.09	-0.05	-0.02	-0.01	-0.01
Net Debt / EBITDA	1.86	5.66	2.25	2.11	2.39
Total Debt / (EBITDA - Capex)	-0.09	-0.05	-0.02	-0.01